Literature DB >> 11774590

Glycodendrimeric ligands of c-type lectin receptors as therapeutic agents in experimental cancer.

M Pospisil1, L Vannucci, A Fiserova, K Krausova, O Horvath, V Kren, F Mosca, T K Lindhorst, K Sadalapure, K Bezouska.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11774590     DOI: 10.1007/978-1-4615-0685-0_48

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  5 in total

1.  Antitumor activity of N-acetyl-D-glucosamine-substituted glycoconjugates and combined therapy with keyhole limpet hemocyanin in B16F10 mouse melanoma model.

Authors:  K Hulíková; V Grobárová; R Křivohlavá; A Fišerová
Journal:  Folia Microbiol (Praha)       Date:  2010-10-13       Impact factor: 2.099

2.  Synthesis of chitooligomer-based glycoconjugates and their binding to the rat natural killer cell activation receptor NKR-P1.

Authors:  T Semenuk; P Krist; J Pavlícek; K Bezouska; M Kuzma; P Novák; V Kren
Journal:  Glycoconj J       Date:  2001-10       Impact factor: 2.916

3.  Re-evaluation of binding properties of recombinant lymphocyte receptors NKR-P1A and CD69 to chemically synthesized glycans and peptides.

Authors:  Daniel Rozbeský; Jana Krejzová; Karel Křenek; Jan Prchal; Richard Hrabal; Milan Kožíšek; Lenka Weignerová; Michele Fiore; Pascal Dumy; Vladimír Křen; Olivier Renaudet
Journal:  Int J Mol Sci       Date:  2014-01-17       Impact factor: 5.923

4.  Synthesis of G0 aminopolyol and aminosugar dendrimers, controlled by NMR and MALDI TOF mass spectrometry.

Authors:  Mikołaj A Pyziak; Grażyna Bartkowiak; Łukasz Popenda; Stefan Jurga; Grzegorz Schroeder
Journal:  Des Monomers Polym       Date:  2016-10-14       Impact factor: 2.650

5.  Nkrp1 family, from lectins to protein interacting molecules.

Authors:  Daniel Rozbeský; Ljubina Ivanova; Lucie Hernychová; Valéria Grobárová; Petr Novák; Jan Černý
Journal:  Molecules       Date:  2015-02-17       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.